Table 4

Summary of internalization data for HCD122 and rituximab in B-CLL cells, n = 8

Patient ID% Internalization*
HCD122Rituximab
C4 −12 53 
C21 18 23 
C22 −9 38 
C27 −14 20 
C30 −43 32 
C31 −71 49 
C32 −14 27 
C33 13 59 
Mean ± SD −16.5 ± 28.8 37.6 ± 14.6 
Patient ID% Internalization*
HCD122Rituximab
C4 −12 53 
C21 18 23 
C22 −9 38 
C27 −14 20 
C30 −43 32 
C31 −71 49 
C32 −14 27 
C33 13 59 
Mean ± SD −16.5 ± 28.8 37.6 ± 14.6 
*

A negative value for percentage internalization represents a GMF at 37°C that is higher than at 4°C.

Close Modal

or Create an Account

Close Modal
Close Modal